Key Points
- Insider purchase: Director David Hallas bought 18,348 shares on December 4 at an average of GBX 109, a transaction valued at £19,999.32.
- Stock snapshot: shares opened at GBX 108.10 with a market cap of £72.96M, a P/E of 44.49, a 12‑month range of GBX 50–114 and 50/200‑day moving averages of GBX 89.52/76.67; the company shows strong liquidity (current ratio 2.96, quick ratio 2.14) but a high debt‑to‑equity of 4.81.
- Mixed fundamentals and bullish analyst view: the company reported a quarterly EPS of GBX (0.54) yet Shore Capital raised its price target from GBX 150 to GBX 160 and gave a "buy" rating, with the consensus target now GBX 160.
ECO Animal Health Group plc (LON:EAH - Get Free Report) insider David Hallas purchased 18,348 shares of the company's stock in a transaction dated Thursday, December 4th. The shares were acquired at an average cost of GBX 109 per share, with a total value of £19,999.32.
ECO Animal Health Group Stock Performance
Shares of ECO Animal Health Group stock opened at GBX 108.10 on Friday. The stock has a market cap of £72.96 million, a price-to-earnings ratio of 44.49 and a beta of -0.05. ECO Animal Health Group plc has a twelve month low of GBX 50 and a twelve month high of GBX 114. The company's fifty day moving average is GBX 89.52 and its 200 day moving average is GBX 76.67. The company has a quick ratio of 2.14, a current ratio of 2.96 and a debt-to-equity ratio of 4.81.
ECO Animal Health Group (LON:EAH - Get Free Report) last announced its earnings results on Monday, December 1st. The company reported GBX (0.54) earnings per share (EPS) for the quarter. ECO Animal Health Group had a return on equity of 1.27% and a net margin of 1.17%.
Wall Street Analysts Forecast Growth
Separately, Shore Capital upped their price objective on shares of ECO Animal Health Group from GBX 150 to GBX 160 and gave the company a "buy" rating in a research note on Tuesday. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of GBX 160.
View Our Latest Research Report on EAH
ECO Animal Health Group Company Profile
(
Get Free Report)
ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.
Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.
Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
